On November 19, Gelonghui reported that sunflower pharmaceutical group (002737.SZ) announced that as of the announcement date, a total of 4.18 million shares of the company held by the 2021 employee stock ownership plan have been completely sold through the secondary market via centralized bidding, accounting for 0.72% of the company's current total equity. According to the relevant regulations of the company's 2021 employee stock ownership plan, this employee stock ownership plan has been completed and terminated early, and subsequent work will be carried out for asset liquidation and related distribution.